ArticleNPJ precision oncology2025

Examining patient-specific responses to PARP inhibitors in a novel, human induced pluripotent stem cell-based model of breast cancer.

Carly J Weddle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.